Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
3034 results found
2025 ∙ Martinez-Serrano, A. Pulido-Fuentes, M. Notario-Pacheco, B. Palmar-Santos, A. M. Cobo-Cuenca, A. I. Diez-Fernandez, A.
Immunity Awareness-Strategies to Improve the Degree of Acceptance of Vaccines: A Systematic Review
All age groups Healthcare workers Parents/caregivers
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Rahimi, H. K. Jasim, A. A. Rezahosseini, O. Harboe, Z. B.
Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis
Adults Older adults Pneumococcal disease Influenza COVID-19 Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Niyati, R. Rezahosseini, O. Ekenberg, C. Larsen, C. S. Harboe, Z. B.
Immunogenicity and Safety of Pneumococcal Vaccines Co-Administered with Common Travel Vaccines in Adults: A Systematic Review +
Adults Older adults Pneumococcal disease Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Terekhov, R. P. Svotin, A. A. Korochkina, M. D. Khodyachikh, A. A. Varnavskiy, M. A. Piniaeva, A. N. Ivin, Y. Y. Zhdanov, D. D. Kozlovskaya, L. I. Taldaev, A.
Immunogenicity and safety of polio vaccines in infants: a systematic review of randomized clinical trials
Newborn Poliomyelitis Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Montes-Sevilla, L. D. Hernandez-Montes, P. E. Ramirez-Garcia, E. Guzman-Rios, E. D. Flores-Reyes, M. F. Acosta-Gutierrez, G. H. Morales-Hernandez, O. Giron-Perez, M. I.
Immunogenicity and safety of tetravalent dengue vaccines: a systematic review of clinical trials
Adults Older adults Dengue Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Chen, Z. Wan, C. Chen, B. Mo, Q. Ju, M. Deng, K. Li, X. Qin, D.
Immunogenicity and safety of the booster COVID-19 vaccine among people with HIV: a systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Yuan, Y. Wang, T. Xia, Y. Shi, Z. He, P.
Immunogenicity and safety of the domestic and imported live-attenuated varicella vaccine in healthy Chinese populations: a systematic review and meta-analysis
Western Pacific China Newborn Children Adolescents Adults Varicella Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Ngamprasertchai, T. Ruenroengbun, N. Kajeekul, R.
Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Adults Older adults Pneumococcal disease Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Martins, A. M. Valero Juan, L. F. Santos, M. Martins, J. P.
Immunogenicity as a Predictor of Influenza Vaccine Efficacy: A Systematic Review
Children Adolescents Adults Older adults Influenza Efficacy/effectiveness Modeling
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Pacheco-Haro, M. D. de Arenas-Arroyo, S. N. Diaz-Goni, V. Velasco-Lucio, E. J. Castellares-Gonzalez, C. I. Reynolds-Cortez, V. Simeon-Prieto, A. Ignateva, E. Martinez-Vizcaino, V.
Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine Versus a 13-Valent Vaccine in Infants: A Systematic Review and Meta-Analysis
Newborn Pneumococcal disease Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
High
Loading...